Unicycive Therapeutics, Inc. (UNCY) stock
UNCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.70+0.00 (0.00%)
Close on Nov 17, 2026Market cap $103.06MP/E –Yield –
Unicycive Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Unicycive Therapeutics's operating margin for the twelve months ending Dec 31, 2023 was -3077.6%. For fiscal 2023 it was -3077.6%, against -1898.2% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -3077.6% | −1179.4 |
| FY2022 | Dec 31, 2022 | -1898.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2023 | Mar 31, 2023 | -622.5% | – |
| Q3 FY2022 | Sep 30, 2022 | -584.0% | – |
See a number that looks wrong?